BALTIMORE — A mixup at a Baltimore plant manufacturing two COVID-19 vaccines has caused approximately 15 million doses of Johnson & Johnson’s vaccines to be ruined, forcing regulators to delay authorization of the plant’s production lines.
The U.S. Food and Drug Administration will investigate the mixup, which will cause a delay in future shipments of Johnson & Johnson vaccines, the newspaper reported. Johnson & Johnson officials said they are working to strengthen their control over Emergent BioSolutions’ processes to avoid further quality lapses.
The delay does not affect Johnson & Johnson’s one-shot doses that are currently being delivered and used nationally, the Times reported. Those doses were produced in the Netherlands.
However, the Baltimore plant had been set to deliver tens of millions of vaccines, so those deliveries are in flux as quality control issues are investigated, according to the Times.
More coronavirus pandemic coverage: